Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this study, hair loss was found to be associated with increased depressive symptoms among MZ generation individuals, particularly affecting women, smokers, and older age groups, suggesting a potential link between hair health and mental well-being.

This study in Ramgati, Bangladesh, found that coastal residents perceive extreme temperatures and high water salinity from climate change as causing various health issues, including heat-related illnesses and maternal health problems, with older individuals and those perceiving a higher risk more affected.

In this case report, the authors documented a fatal instance of Stevens-Johnson syndrome in an elderly woman potentially triggered by doxycycline and flucloxacillin, emphasizing the importance of recognizing such rare but severe drug reactions in older patients.

This study at NYU Langone Health suggests that younger patients with androgenetic alopecia may experience greater improvements in hair density with PRP treatment compared to older patients, who might need more sessions for similar results.

This article discusses hair loss disorders, underscoring the recent therapeutic advance of ritlecitinib, approved for severe alopecia areata in individuals aged 12 and older, and the ongoing need to manage expectations given limited treatment options.

This study found that negative societal perceptions of individuals with baldness, such as being seen as less confident, attractive, or older, are predominantly influenced by social stereotypes and a lack of understanding about the medical causes of baldness.

In this case-control study, researchers observed that smoking and lighter hair color significantly increased the risk of developing androgenetic alopecia, with older individuals and women showing higher prevalence rates, while hair thickness and shape were not linked to increased alopecia risk.

In this study, 37.5% of alopecia areata patients treated with tofacitinib were identified as super-responders, with significant predictors for this status being older age and no prior JAK inhibitor treatment, leading to faster and sustained hair regrowth.

This study found that snoring during sleep, frequent consumption of bacon and preserved meats, and drinking unboiled water, along with older age and suboptimal health, were associated with a higher likelihood of female androgenetic alopecia in a community-based sample of women in China.

This study found that cataracts, hair changes, short stature, and low bodyweight are key indicators for diagnosing Werner syndrome in patients under 30, differing from older age group symptoms.

This source reports that clascoterone cream, a topical androgen receptor inhibitor, has shown effectiveness in treating facial acne vulgaris in patients 12 and older, with clinical trials indicating a favorable safety profile compared to systemic treatments, and potential for broader dermatological applications.

This study found that Bangladeshi patients with type 2 diabetes mellitus had significantly lower serum vitamin E levels compared to healthy individuals, with lower levels particularly observed in female and older patients, emphasizing the potential importance of antioxidant status in managing the disease.

According to this worldwide systematic review, psoriasis is a prevalent disease with adult prevalence ranging from 0.53% to 11.48%, more common in older populations and with substantial knowledge gaps in low and middle-income countries.

This study explored social perceptions of men with androgenetic alopecia, finding that increased hair loss was associated with perceptions of being older, less attractive, smaller, and less masculine, but more family-oriented and socially agreeable, highlighting how hair loss influences first impressions.

In this study, the author explores ancient Egyptian attitudes towards male pattern baldness through interdisciplinary and biblical feminist perspectives, revealing that baldness was recognized as unattractive yet also associated with respect for older men's work ethic and masculinity.

This study found that ritlecitinib, taken daily, led to scalp, eyebrow, and eyelash hair regrowth in patients aged 12 and older with severe and very severe alopecia areata over a 24-month period.

This study observed that in a survey of individuals with scarring alopecia, those using chemical treatments or high-tension hairstyles experienced hair loss and alopecia diagnosis at a younger age, while hair dye use was linked to older age at hair loss onset and diagnosis.

In this review, the authors highlight the FDA approval of Ritlecitinib, the first oral treatment specifically for moderate to severe alopecia areata in patients aged 12 and older, marking a significant advancement in managing this condition.

This paper argues that for lupus management, selective immunotherapies like anifrolumab and belimumab, which specifically target parts of the immune system, offer more effective treatment options compared to older, broad immunosuppressive strategies.

In this case report, researchers observed that local radiation therapy to the orbits may not be sufficient to halt progression of new retinal lesions in older patients, even when the disease initially appears confined to the intraocular space.

In this study, researchers found that female pattern hair loss significantly reduces quality of life, particularly affecting younger women who experience more stigmatization, poorer emotional stability, and higher dermatology life quality index scores compared to older women.

This study reports that ritlecitinib, when used for up to 24 months in patients aged 12 and older with alopecia areata, has an acceptable safety profile, with a similar proportion of adverse events in both ritlecitinib and placebo groups in the placebo-controlled cohort.

In this study, baricitinib treatment over an average of 18.5 months resulted in a 72% reduction in alopecia severity scores among patients aged 65 or older, with mild adverse effects and no severe complications reported.

In this report, NICE has approved ritlecitinib, an oral kinase inhibitor, as the first recommended treatment for severe alopecia areata in individuals aged 12 and older.

This study reviews international findings on how COVID-19 affected dermatology visits, noting varied impacts with some regions experiencing persistent declines, and examines expected shifts in patient demographics, including fewer visits from older and minority patients with chronic conditions after the pandemic onset.

In this study, exome sequencing revealed that two brothers with ichthyosis, born to consanguineous parents, had NIPAL4 autosomal recessive congenital ichthyosis, while the older brother's blindness resulted from separate mutations in the peroxidasin gene, which were also found in an unaffected sister.

In this study, Ritlecitinib was reported as a newly approved treatment for alopecia areata that can be used in patients aged 12 and older; after 24 weeks, it resulted in 80% or more scalp hair coverage in treated patients compared to a placebo.

This source reports that clascoterone cream has been approved in the U.S. for treating acne vulgaris in patients aged 12 and older, suggesting it works by competing with dihydrotestosterone at androgen receptors to mitigate acne's effects.

This article reviews the epidemiology of desmoplastic melanoma and reports no new clinical findings, emphasizing higher risks in chronically sun-exposed older males.

This study reviewed 41 cases of lichen planus pigmentosus in patients from southeastern Tunisia, highlighting its prevalence among older individuals and notable differences compared to patterns observed in an Indian cohort.